NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
Back to search
Official data from USPTO
INCEREBRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/07/2023
Trademark type
Combined
Nice classes
42
Filing date
03/12/2021
Registration date
03/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
03/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
5
Owner type
03
Owner location
Seoul, KR
Examiner
LATTUCA, FRANK
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "inCerebro" with the "in" portion shown in gray, the "erebro" portion shown in black, and the "C" shown in different gradations of blue, gray and black.
Holders and representatives
Holders
inCerebro Co.,Ltd.
Representatives
Boris Umansky LADAS & PARRY LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research in the field of pharmaceuticals; pharmaceutical research services; pharmaceutical drug development services; inspection of pharmaceuticals; pharmaceutical products evaluation; conducting clinical trials for others; scientific research services for assessing the efficiency of pharmaceuticals; scientific research in the fields of medicine/health and pharmacology; product development consultationanalysis and evaluation of medical product development; platform as a service (paas) featuring computer software platform for testinganalyzingresearchingevaluating the effects of drug for discovery; software as a service (saas) featuring software for testinganalyzingresearchingevaluating the effects of drug for discovery; development of computer platforms for computing drug discovery; working on and evaluation of chemical syntheses; laboratory research in the field of medicine; computer programming in the medical field; molecular analysis for scientific research purposes; computerized analysis of datadata miningcomputer programming and computer modelling for data analysis
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/14/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/03/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/16/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/16/2022
CNSI
SUSPENSION INQUIRY WRITTEN
10/16/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2022
CNSL
SUSPENSION LETTER WRITTEN
04/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/18/2021
GNRT
NON-FINAL ACTION E-MAILED
10/18/2021
CNRT
NON-FINAL ACTION WRITTEN
10/18/2021
DOCK
ASSIGNED TO EXAMINER
10/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2021
NWAP
NEW APPLICATION ENTERED
03/16/2021
Continuous trademark protection
Get notified about every new filing that threatens INCEREBRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.